Confirm the clinical picture
History, repeat morning testosterone testing and relevant hormone findings inform the discussion.
A separate testosterone-care decisionDifferent mechanism.
Different mechanism.
Individual suitability.
Enclomiphene belongs in a clinician-led hormone conversation—not a default alternative, an automatic add-on or a fertility promise.
A considered approach01 02 03
Evaluation before a choice.
Discuss fertility explicitly
Fertility plans matter when considering testosterone care. Hormone values alone do not establish fertility.
Review the evidence
Benefits, risks, alternatives and the limits of long-term evidence are considered before any prescription.
Care option
Enclomiphene.
An oral hormone-care option considered separately from testosterone replacement, with an individual clinical evaluation and monitoring.
Compounded enclomiphene is not FDA-approved. The FDA does not verify the safety, effectiveness or quality of compounded preparations. No fertility or pregnancy outcome is guaranteed. Product imagery shows a format, not verified dispensed packaging; formulations and availability vary.
Discuss at a consultationA closer look
Options with context.
A different hormone pathway
Enclomiphene is a selective estrogen receptor modulator studied for endogenous testosterone stimulation in selected men. Suitability is not interchangeable with TRT.
Monitoring is individualized
Relevant testing may include testosterone, LH/FSH and estradiol. Fertility-specific questions may require separate assessment; laboratory hormone values are not a semen analysis.
Safety deserves a conversation
The clinic discusses headaches, abdominal discomfort, estradiol changes and limited long-term safety data. Visual or mood concerns associated with related medicines require clinician review; a prescription is not an automatic next step.
Costs, stated clearlyA consultation.
A consultation.
A separate care decision.
Self-pay. No insurance billing. HSA/FSA eligibility depends on the individual plan. The clinic confirms the complete cost before care begins.
View all pricingThe program: medication if prescribed, provider follow-up, review of follow-up labs and dose adjustments. The $49 first consultation and initial labs are separate: $50 in our Houston office, or self-pay at any Quest location. Follow-up, additional and repeat lab fees are separate.
Book NowBefore a conversation
A few clear answers.
Clinical context matters. These answers explain the process, not an individual recommendation.
Is enclomiphene FDA-approved?
Compounded enclomiphene is not FDA-approved. Product status, clinical evidence, risks and alternatives must be reviewed separately from treatment goals.
Does treatment guarantee preserved fertility?
No. Fertility and pregnancy outcomes are not guaranteed. Hormone testing alone does not establish fertility; the appropriate evaluation is individualized.
How does this relate to TRT?
It is a different treatment conversation, not an automatic replacement or combined regimen. Clinical findings, fertility plans and suitability guide the choice; sometimes no medication is recommended.
Separate questions. Connected evaluation.
Patients notice the difference.
“For the first time, I felt really heard about my concerns.”
“I felt truly helped, educated and properly prepared for my future health journey.”
“It’s not one-size-fits-all, it’s catered to you.”
Excerpts from Google reviews. Individual results vary.
Let’s talk
Start with a conversation.
Houston clinic. Texas telehealth.